Preventive Health Care in the Elderly Population: A Guide for Practicing Physicians

Mayo Clinic Proceedings

Volumn 79, Issue 3, 2004, Pages 416-427

  Takahashi, Paul Y ^a   Okhravi, Hamid R ^a,b   Lim, Lionel S ^a   Kasten, Mary J ^a  

^a Mayo Clinic   (United States)

^b Bradley Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

AGE; AGED; AGING; BARIUM ENEMA; CANCER; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COLONOSCOPY; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DENTITION; EVIDENCE BASED MEDICINE; EXERCISE; GERIATRIC CARE; GERIATRICS; HEARING DISORDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNIZATION; INFLUENZA; LIFE EXPECTANCY; LIFESTYLE; LIVING WILL; NUTRITION; OCCULT BLOOD TEST; OSTEOPOROSIS; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; SCREENING; SENSORY DYSFUNCTION; SIGMOIDOSCOPY; SMOKING CESSATION; STREPTOCOCCUS INFECTION; TETANUS; TRAVEL; VISUAL DISORDER;

EID: 1442282194     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.3.416     Document Type: Conference Paper

References (99)

1. Population Projects Program. United States Bureau of the Census, Washington, DC; 2000. Available at: www.census.gov. Accessibility verified February 6, 2004.
2. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
3. Health and Public Policy Committee, American College of Physicians. Comprehensive functional assessment for elderly patients. Ann Intern Med. 1988;109:70-72.
4. Hays JT, Dale LC, Hurt RD, Croghan IT. Trends in smoking-related diseases: why smoking cessation is still the best medicine. Postgrad Med. 1998;104:56-62, 65-66, 71.
5. Biesalski HK, de Mesquita BB, Chesson A, et al, Lung Cancer Panel. European Consensus Statement on Lung Cancer: risk factors and prevention. CA Cancer J Clin. 1998;48:167-176.
6. Rennard SI. COPD: overview of definitions, epidemiology, and factors influencing its development. Chest. 1998;113(suppl):235S-241S.
7. Lakier JB. Smoking and cardiovascular disease. Am J Med. 1992;93:8S-12S.
8. US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2000.
9. Fazio CJ. Pocket Guidelines April 2000 Edition. Bloomington, Minn: Institute for Clinical Systems Improvement; 2000.
10. Chin APMJ, de Jong N, Schouten EG, Hiddink GJ, Kok FJ. Physical exercise and/or enriched foods for functional improvement in frail, independently living elderly: a randomized controlled trial. Arch Phys Med Rehabil. 2001;82:811-817.
11. Yu CM, Lau CP, Cheung BM, et al. Clinical predictors of morbidity and mortality in patients with myocardial infarction or revascularization who underwent cardiac rehabilitation, and importance of diabetes mellitus and exercise capacity. Am J Cardiol. 2000;85:344-349.
12. Holloszy JO. The biology of aging. Mayo Clin Proc. 2000;75(suppl):S3-S8.
13. Vellas B, Lauque S, Andrieu S, et al. Nutrition assessment in the elderly. Curr Opin Clin Nutr Metab Care. 2001;4:5-8.
14. McGee M, Jensen GL. Nutrition in the elderly. J Clin Gastroenterol. 2000;30:372-380.
15. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. Rockville, Md: US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
16. Nelson DE, Sacks JJ, Chorba TL. Required vision testing for older drivers. N Engl J Med. 1992;326:1784-1785.
17. Mulrow CD, Lichtenstein MJ. Screening for hearing impairment in the elderly: rationale and strategy. J Gen Intern Med. 1991;6:249-258.
18. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
19. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
20. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-2572.
21. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-2572.
22. Shepherd J, Cobbe SM, Ford I, et al, West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
23. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
24. National Institutes of Health. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report. Bethesda, Md: National Institutes of Health; 2001. Publication NIH 01-3670.
25. Hodgson SF, Watts NB, Bilezikian JP, et al, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Endocr Pract. 2001;7:293-312.
26. Rudy DR, Zdon MJ. Update on colorectal cancer. Am Fam Physician. 2000;61:1759-1770, 1773-1774.
27. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
28. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ. 1998;317:559-565.
29. Heflin MT, Cohen HJ. Cancer screening in the elderly. Hosp Pract (Off Ed). 2001;36:61-69.
30. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
31. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
32. Winawer SJ, Zauber AG, O'Brien MJ, et al, National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med. 1993;328:901-906.
33. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G, Veterans Affairs Cooperative Study Group 380. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;343:162-168.
34. Winnan G, Berci G, Panish J, Talbot TM, Overholt BF, McCallum RW. Superiority of the flexible to the rigid sigmoidoscope in routine proctosigmoidoscopy. N Engl J Med. 1980;302:1011-1012.
35. Gedebou TM, Wong RA, Rappaport WD, Jaffe P, Kahsai D, Hunter GC. Clinical presentation and management of iatrogenic colon perforations. Am J Surg. 1996;172:454-457.
36. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555-560.
37. Silverman MA, Zaidi U, Barnett S, et al. Cancer screening in the elderly population. Hematol Oncol Clin North Am. 2000;14:89-112.
38. Ristikankare M, Hartikainen J, Heikkinen M, Janatuinen E, Julkunen R. The effects of gender and age on the colonoscopic examination. J Clin Gastroenterol. 2001;32:69-75.
39. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31.
40. Balducci L, Schapara DV, Cox CE, Greenberg HM, Lyman GH. Breast cancer of the older woman: an annotated review. J Am Geriatr Soc. 1991;39:1113-1123.
41. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-1998. Bethesda, Md: National Cancer Institute; 2001. Available at: http://seer.cancer.gov/csr/1973_1998/. Accessibility verified January 16, 2004.
42. Cady B, Steele GD Jr, Morrow M, et al. Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin. 1998;48:49-63.
43. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993;85:1644-1656.
44. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996;276:33-38.
45. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 1993;270:2444-2450.
46. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA. 1995;273:149-154.
47. van Dijck JA, Holland R, Verbeek AL, Hendriks JH, Mravunac M. Efficacy of mammographic screening of the elderly: a case-referent study of the Nijmegen program in the Netherlands. J Natl Cancer Inst. 1994;86:934-938.
48. van Dijck JA, Verbeek AL, Beex LV, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer. 1996;66:727-731.
49. Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions: a decision analysis model. Ann Intern Med. 1992;116:722-730.
50. Beahrs OH, Shapiro S, Smart C, McDivitt RW. Report of the working group to review the National Cancer Institute-American Cancer Society breast cancer detection demonstration projects. J Natl Cancer Inst. 1979;62:639-709.
51. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
52. Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer. 1995;60:1-26.
53. Herrero R, Brinton LA, Reeves WC, et al. Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol. 1992;21:1050-1056.
54. Remington P, Lantz P, Phillips JL. Cervical cancer deaths among older women: implications for prevention. Wis Med J. 1990;89:30, 32-34.
55. Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B. The validation of cervical cytology: sensitivity, specificity and predictive values. Acta Cytol. 1991;35:8-14.
56. Benoit AG, Krepart GV, Lotocki RJ. Results of prior cytologic screening in patients with a diagnosis of stage I carcinoma of the cervix. Am J Obstet Gynecol. 1984;148:690-694.
57. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.
58. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference statement on cervical cancer. Gynecol Oncol. 1997;66:351-361.
59. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2000;50:34-49.
60. American Geriatrics Society. Screening for cervical carcinoma in older women. J Am Geriatr Soc. 2001;49:655-657.
61. Ries L, Eisner M, Kosary C, et al. SEER Cancer Statistics Review, 1973-1997. Bethesda, Md: National Cancer Institute; 2000. Available at: http://seer.cancer.gov/csr/1973_1997/. Accessibility verified January 16, 2004.
62. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17:337-347.
63. Barry MJ. Clinical practice: prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med. 2001;344:1373-1377.
64. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151:1283-1290.
65. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: ALSO: update 2001-testing for early lung cancer detection [published correction appears in CA Cancer J Clin. 2001;51:150]. CA Cancer J Clin. 2001;51:38-75.
66. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: ALSO: update 2001-testing for early lung cancer detection [published correction appears in CA Cancer J Clin. 2001;51:150]. CA Cancer J Clin. 2001;51:38-75.
67. Screening for prostate cancer. In: U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996:119-134.
68. American College of Physicians. Screening for prostate cancer. Ann Intern Med. 1997;126:480-484.
69. American Cancer Society. Cancer Facts and Figures 2004. Atlanta, Ga: American Cancer Society; 2004.
70. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer. 2001;92:153-159.
71. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984;130:561-565.
72. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2001;50(RR-4):1-46.
73. Delayed influenza vaccine availability for 2001-02 season and supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2001;50:582-585.
74. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49(RR-3):1-38.
75. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46(RR-8):1-24.
76. Influenza and pneumococcal vaccination levels among persons aged ≥65 years-United States, 1999. MMWR Morb Mortal Wkly Rep. 2001;50:532-537.
77. Nicol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784.
78. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665-670.
79. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661-1665.
80. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
81. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized placebo-controlled trial. JAMA. 1990;264:1139-1141.
82. Farr BM, Johnston BL, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study. Arch Intern Med. 1995;155:2336-2340.
83. Shapiro ED, Clemens JD. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med. 1984;101:325-330.
84. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988;108:653-657.
85. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med. 1994;154:2666-2677.
86. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453-1460.
87. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA. 1993;270:1826-1831.
88. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997;278:1333-1339.
89. Gable CB; Holzer SS, Engelhart L, et al. Pneumococcal vaccine: efficacy and associated cost savings. JAMA. 1990;264:2910-2915.
90. Rigau-Perez JG, Overturf GD, Chan LS, Weiss J, Powars D. Reactions to booster pneumococcal vaccination in patients with sickle cell disease. Pediatr Infect Dis. 1983;2:199-202.
91. Rodriguez R, Dyer PD. Safety of pneumococcal revaccination. J Gen Intern Med. 1995;10:511-512.
92. Hilleman MR, Carlson AJ Jr, McLean AA, Vella PP, Weibel RE, Woodhour AF. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis. 1981;3(suppl):S31-S42.
93. Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance-United States, 1995-1997. MMWR CDC Surveill Summ. 1998;47:1-13.
94. LaForce FM, Young LS, Bennett JV. Tetanus in the United States (1965-1966): epidemiologic and clinical features. N Engl J Med. 1969;280:569-574.
95. Leder K, Weller PF, Wilson ME. Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis. 2001;33:1553-1566.
96. Martin M, Tsai TF, Cropp B, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet. 2001;358:98-104.
97. Martin M, Weld LH, Tsai TF, et al. Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis. 2001;7:945-951.
98. Joint Commission on Accreditation of Healthcare Organizations. Standards most likely to result in type 1 recommendations. Ambulatory Care Advisor. 2001;2.
99. Minino AM, Smith BL. Deaths: preliminary data for 2000. Natl Vital Stat Rep. 2001;49:1-40.